A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer

Fang Zhao, Ekaterina Olkhov-Mitsel, Shivani Kamdar, Renu Jeyapala, Julia Garcia, Rachel Hurst, Marcelino Yazbek Hanna, Robert Mills, Alexandra V. Tuzova, Eve O’Reilly, Sarah Kelly, Colin Cooper, Daniel Brewer, Antoinette S. Perry, Jeremy Clark, Neil Fleshner, Bharati Bapat
  • Clinical Epigenetics, November 2018, Springer Science + Business Media
  • DOI: 10.1186/s13148-018-0575-z

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Daniel Brewer

In partnership with: